داء غريفز I: مقدمة

Graves' disease develops when the immune system produces thyroid-stimulating immunoglobulins, autoantibodies that abnormally activate the thyroid gland. These antibodies bind to TSH receptors on thyroid cells, triggering excessive hormone production. The condition combines genetic predisposition—particularly HLA-DR3 and HLA-B8 variants—with environmental triggers such as smoking, stress, and viral infections.

Thyroid-stimulating immunoglobulins bind to TSH receptors on the thyroid gland, leading to excessive production of thyroid hormones. This increases the body's metabolic rate and disrupts functions such as heart rate and temperature regulation, creating a hypermetabolic state characteristic of hyperthyroidism.

Graves' disease presents with weight loss, heat intolerance, palpitations, tachycardia, tremors, anxiety, and menstrual irregularities. A diffuse goiter typically causes visible neck swelling. Ophthalmopathy, a distinctive autoimmune feature, includes exophthalmos, eye dryness, redness, and in severe cases, visual disturbances or pain.

Graves' disease has a strong genetic component, with increased prevalence in individuals carrying HLA-DR3 and HLA-B8 alleles. These specific HLA types present thyroid proteins in an altered manner, increasing the likelihood of activating autoreactive T cells. Family clustering and higher concordance in monozygotic twins demonstrate the hereditary nature of susceptibility.

Graves' disease is associated with other autoimmune disorders such as type 1 diabetes and pernicious anemia, indicating underlying immune dysfunction. This clustering suggests shared genetic predisposition and common mechanisms of immune dysregulation that increase risk for multiple autoimmune conditions simultaneously.

Ophthalmopathy is a distinctive autoimmune feature of Graves' disease characterized by exophthalmos, or forward bulging of the eyes, along with periorbital edema. Patients experience eye dryness, redness, tearing, and diplopia. In severe cases, visual disturbances or pain may occur, making ophthalmopathy a defining clinical marker.

Environmental triggers include smoking, which significantly aggravates ophthalmopathy, viral infections through molecular mimicry mechanisms, emotional stress, and excess iodine intake. These factors interact with genetic predisposition to disrupt immune regulation, leading to B-cell production of thyroid-stimulating immunoglobulins and disease initiation or progression.